In Anderson v. Wilson, a claim was
approved against a physician running EEG clinics in Toronto after a possible link was identified with a Hepatitis B outbreak.
Despite the passionate testimony, the advisory committee voted seven to six
against approving eteplirsen for sale — though this was only a recommendation they would make to
physician Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research (CDER).